Patents by Inventor Mitchell Lewis

Mitchell Lewis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240059691
    Abstract: The present invention provides compounds of formula (I): compositions comprising such compounds; the use of such compounds in medicine; and methods of treating patients with such compounds; wherein A, W, R5, n, Z, X, Y and B are as defined herein. The present invention also relates to compounds useful as synthetic intermediates of compounds of formula (I).
    Type: Application
    Filed: December 1, 2021
    Publication date: February 22, 2024
    Inventors: Mitchell Lewis CHILDS, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, William Jack GREVES, Simon Teanby HODGSON, Alessandro MAZZACANI, Carl Leslie NORTH, Alicja Stela OBARA, Michael Bryan ROE, David Philip ROOKER, Michael John STOCKS, Louise Michelle BIRCH, Mark PICHOWICZ, Rachael PITTAWAY, Alun John SMITH, Adam Eric THROUP, Joseph William WRIGGLESWORTH, Xuezheng YANG, David Edward CLARK
  • Publication number: 20220289727
    Abstract: The present invention provides compounds of formula (I) or (Ia) compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, B, n, R2, R3, R4, R5, and R6 are as defined herein.
    Type: Application
    Filed: February 13, 2020
    Publication date: September 15, 2022
    Inventors: Mitchell Lewis CHILDS, Rebecca Louise DAVIE, Hannah Joy EDWARDS, David Michael EVANS, Simon Teanby HODGSON, Alessandro MAZZACANI, David Edward CLARK, Paul Stuart HINCHLIFFE, Thomas Matthew BAKER, Colin Peter SAMBROOK SMITH, Alun John SMITH, Joseph William WRIGGLESWORTH, Xuezheng YANG
  • Patent number: 10392622
    Abstract: A self-regulating gene expression construct comprises a single promoter in operative association with a repressor sequence (e.g., bacterial repressor lacI or gaiR), operator sequence(s) responsive to the expressed repressor protein, and a transgene. A dual-regulating construct comprises a single promoter controlling expression of a bacterial repressor sequence and a transgene, and which, in the presence of a first inducer molecule, transcribes the transgene and repressor; and a ribozyme in association with an aptamer sequence, the aptamer sequence capable of interacting with a second inducer molecule to terminate mRNA degradation by the ribozyme. Also provided are recombinant vectors or viruses containing the self-regulating or dual self-regulating constructs and cells containing the vectors. Such compositions are useful in methods of treating a diseases using gene therapy.
    Type: Grant
    Filed: July 31, 2015
    Date of Patent: August 27, 2019
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Mitchell Lewis, Jean Bennett, Luk Vandenberghe, Matthew Sochor, Theodore G. Drivas
  • Patent number: 9868229
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Grant
    Filed: October 28, 2015
    Date of Patent: January 16, 2018
    Assignee: US SYNTHETIC CORPORATION
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Publication number: 20170218379
    Abstract: A self-regulating gene expression construct comprises a single promoter in operative association with a repressor sequence (e.g., bacterial repressor lacI or gaiR), operator sequence(s) responsive to the expressed repressor protein, and a transgene. A dual-regulating construct comprises a single promoter controlling expression of a bacterial repressor sequence and a transgene, and which, in the presence of a first inducer molecule, transcribes the transgene and repressor; and a ribozyme in association with an aptamer sequence, the aptamer sequence capable of interacting with a second inducer molecule to terminate mRNA degradation by the ribozyme. Also provided are recombinant vectors or viruses containing the self-regulating or dual self-regulating constructs and cells containing the vectors. Such compositions are useful in methods of treating a diseases using gene therapy.
    Type: Application
    Filed: July 31, 2015
    Publication date: August 3, 2017
    Inventors: Mitchell LEWIS, Jean BENNETT, Luk VANDENBERGHE, Matthew SOCHOR, Theodore G. DRIVAS
  • Publication number: 20160046042
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Application
    Filed: October 28, 2015
    Publication date: February 18, 2016
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Patent number: 9199400
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Grant
    Filed: March 4, 2014
    Date of Patent: December 1, 2015
    Assignee: US SYNTHETIC CORPORATION
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Publication number: 20140183788
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Application
    Filed: March 4, 2014
    Publication date: July 3, 2014
    Applicant: US SYNTHETIC CORPORATION
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Patent number: 8702412
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Grant
    Filed: May 3, 2012
    Date of Patent: April 22, 2014
    Assignee: US Synthetic Corporation
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Publication number: 20120213884
    Abstract: Embodiments of the invention relate to injection mold components, assemblies, and molding system that include superhard materials. Such injection mold components, assemblies, and systems may decrease wear of certain injection mold components, which may result in improved productivity of the injection mold and molding systems that utilize such components.
    Type: Application
    Filed: May 3, 2012
    Publication date: August 23, 2012
    Applicant: US SYNTHETIC CORPORATION
    Inventors: Robert Keith Judd, Terry Mitchell Lewis
  • Publication number: 20080289156
    Abstract: A zipper construction includes first and second fabric pieces. Each of the first and second fabric pieces includes an inner edge to which teeth are affixed. The first and second fabric pieces are formed of a weave defined by pre-dyed warp fibers formed of a substantially inelastic material and weft fibers that are formed of an elastic material. The zipper construction also includes a slider that engages the teeth of the first and second fabric pieces.
    Type: Application
    Filed: May 23, 2008
    Publication date: November 27, 2008
    Inventors: Mitchell Lewis, Richard Schiff
  • Patent number: 5683356
    Abstract: A compound or composition incorporating silver carbonate is for use in removing excess hydrogen ions in a patient. The silver carbonate reacts with chloride ions which naturally occur in the patient's body fluids to produce a silver chloride precipitate. The chemical reaction producing silver chloride causes the release of hydroxyl, carbonate and/or bicarbonate ions which react with free hydrogen ions to form carbon dioxide and water. The silver carbonate compound or composition may be provided in a blood filtration cartridge, syringe or an orally ingestible form either alone or surrounded by a selectively permeable membrane. The membrane is selected to permit movement of ions, as well as carbon dioxide and water molecules therethrough, while preventing the silver carbonate or silver chloride precipitate from being released into the patient.
    Type: Grant
    Filed: July 1, 1996
    Date of Patent: November 4, 1997
    Assignee: Rossmark Medical Publishers Inc.
    Inventors: Mitchell Lewis Halperin, Surinder Cheema-Dhadli